Began career in private equity and investment banking at Goldman Sachs (Associate), advising on AI, healthcare, and consumer transactions; later corporate development at MorphoSys, co-leading early-stage VC investments and contributing to a substantial acquisition. Track record includes IPO and equity engagements (Autolus Therapeutics—NASDAQ: AUTL; MorphoSys AG—FSE: MOR; BenevolentAI). Applicable skills span M&A execution, corporate finance, and innovation/entrepreneurship research. PhD candidate and research associate (RWTH Aachen University); BSc in General Management (EBS Business School).